Trial Profile
Intravenous/Subcutaneous FIH Study of REGN1154 in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Jan 2014
Price :
$35
*
At a glance
- Drugs REGN 1154 (Primary)
- Indications Unspecified
- Focus Adverse reactions
- 28 Jan 2014 New trial record